Glazer Capital LLC’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-39,809
| Closed | -$439K | – | 138 |
|
|
2024
Q1 | $439K | Buy |
39,809
+9,170
| +30% | +$101K | 0.05% | 103 |
|
|
2023
Q4 | $334K | Buy |
+30,639
| New | +$334K | 0.03% | 121 |
|
|
2023
Q2 | – | Sell |
-2,220,305
| Closed | -$23.3M | – | 227 |
|
|
2023
Q1 | $23.3M | Sell |
2,220,305
-4,198
| -0.2% | -$44K | 1.27% | 14 |
|
|
2022
Q4 | $22.9M | Buy |
2,224,503
+112,312
| +5% | +$1.16M | 0.59% | 61 |
|
|
2022
Q3 | $21.4M | Buy |
2,112,191
+70,083
| +3% | +$711K | 0.39% | 75 |
|
|
2022
Q2 | $20.4M | Buy |
+2,042,108
| New | +$20.4M | 0.51% | 51 |
|